Pentoknase Tablets (Calidinogenase)

Adult dose

Administer 30-150 I.U. orally in 3 divided doses daily. Adjust the dose appropriately according to age and symptoms.

This drug should not be used in patients who have just experienced a cerebrovascular hemorrhage or are actively bleeding. In addition, this drug contains lactose, therefore individuals with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take it. When taking this drug, hypersensitivity reactions such as skin rashes or itching may occur, so if such symptoms arise, the medication should be discontinued immediately. Palpitations may also occur rarely, so caution is needed. In the gastrointestinal system, symptoms such as stomach discomfort, nausea, vomiting, reduced appetite, abdominal pain, and diarrhea or constipation may appear. Additionally, symptoms such as fever, headache, heavy-headedness, drowsiness, and fatigue may occur rarely. Especially for older individuals, whose body functions may be weakened, careful management such as dosage reduction should be performed when using this drug.

• Rash
• itching
• palpitations
• upper abdominal discomfort
• nausea
• vomiting
• loss of appetite
• epigastric pain
• diarrhea
• constipation

This medication should be stored in a tightly closed container to prevent air exposure and at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the drug's efficacy and prevent deterioration.

Appearance

White round enteric-coated film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle